these were all correctly characterised by counsel for pharm-a-care and imf as " pleading points ".
on 23 december 2008 the applicant in the current proceeding, pharm-a-care laboratories pty ltd, filed an application and a statement of claim naming the commonwealth of australia as first respondent and five officers of the therapeutic goods administration (tga) as the second to sixth respondents.
the second to sixth respondents are to pay the costs of imf (australia) limited and pharm-a-care laboratories pty ltd. i certify that the preceding forty-one (41) numbered paragraphs are a true copy of the reasons for judgment herein of the honourable justice flick.